Ostrum Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
2,041
+976
+92% +$626K 0.06% 206
2025
Q4
$721K Sell
1,065
-136
-11% -$92.6K 0.03% 330
2025
Q3
$767K Sell
1,201
-94
-7% -$57.1K 0.03% 353
2025
Q2
$695K Sell
1,295
-20
-2% -$9.56K 0.03% 371
2025
Q1
$552K Sell
1,315
-169
-11% -$73.4K 0.03% 400
2024
Q4
$614K Sell
1,484
-528
-26% -$232K 0.05% 375
2024
Q3
$1.02M Sell
2,012
-32
-2% -$15.5K 0.08% 306
2024
Q2
$996K Sell
2,044
-29
-1% -$14.6K 0.09% 301
2024
Q1
$1.12M Buy
2,073
+617
+42% +$337K 0.09% 327
2023
Q4
$808K Buy
1,456
+598
+70% +$281K 0.07% 353
2023
Q3
$375K Sell
858
-1,229
-59% -$613K 0.03% 487
2023
Q2
$1.05M Buy
2,087
+3
+0.1% +$1.44K 0.09% 310
2023
Q1
$1.04M Buy
+2,084
New +$997K 0.09% 298

Other funds holding IDXX

Ostrum Asset Management's IDXX Position: Q1 2026 in Review

Ostrum Asset Management increased its Idexx Laboratories (IDXX) stake by 92% in Q1 2026, buying an estimated $626K and bringing the position to 2,041 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #206.

Ostrum Asset Management first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Ostrum Asset Management held 2,041 shares of Idexx Laboratories worth $1.15M as of Q1 2026.
  • Ostrum Asset Management bought 976 Idexx Laboratories shares in Q1 2026, an estimated $626K.
  • Idexx Laboratories made up 0.06% of Ostrum Asset Management's portfolio in Q1 2026, its #206 holding.
  • Ostrum Asset Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.